AASLD 2023 - HistoIndex

Impact of sampling size on variability of fibrosis assessment in liver biopsies using SHG TPE and AI analysis based fibrosis staging

Kutbuddin Akbary, Elaine Chng, Yayun Ren, Dean Tai, Jonathan A. Fallowfield, Timothy J. Kendall, Nikolai V. Naoumov, David E. Kleiner, and Arun J. Sanyal

NITs as continuous measure of hepatic fibrosis in NAFLD

En Ying Tan, Xian Xuan Eunice Tan, Daniel Q Huang, Jonathan Lee, Margaret Li Peng Teng, Nur Halisah Jumat, Dean Tai, Elaine Chng, Yong Young Dan, and Mark Dhinesh Muthiah

Validation of the HI AI DP platform as an aiding tool to increase pathologist concordance on fibrosis staging in NASH

Desiree Abdurrachim, Serene Lek, Yongqi Zhou, Chun Kit Wong, Charlene Ong, Ashmita Saigal, Radha Krishnan, Geoffrey Walford, Elaine Chng, Dean Tai, Gideon Ho, Annaswamy Raji, Thomas Forest, Richard Baumgartner, Saswata Talukdar, Chih-Liang Chin, Samuel S Engel, Asad Abu Bakar Ali, David E Kleiner, and Arun J Sanyal

Reducing screen failure rates for NASH clinical trials using ballooning and fibrosis assessment with SHG TPE microscopy and AI analysis – results from the TANDEM trial

Naim Alkhouri, Kutbuddin Akbary, Ya-Yun Ren, Dean Tai, Dominique Brees, and Jossy Kochuparampil

Spatial distribution of collagen in MASLD affects levels of N terminal pro-peptide of type III collagen (PRO-C3)

Jörn M. Schattenberg, Maurice Michel, Christian Labenz, Morten A Karsdal, Diana J Leeming, Peder Frederiksen, Elaine Chng, Yayun Ren, Dean Tai, and Beate K. Straub

The concomitant zonal quantification of qSteatosis and qFibrosis using HI AI DP improved detection of liver injury regression post-bariatric surgery

Vlad Ratziu, Raluca Pais, Judith Aron-Wisnewsky, Frédéric Charlotte, Dean Tai, Elaine Chng, Desiree Abdurrachim, Chih-Liang Chin, Saswata Talukdar, and Asad Abu Bakar Ali

Assessment of resmetiron-mediated reductions of steatosis and concomitant ballooning utilizing quantitative SHG imaging

Dean Tai, Rebecca Taub, Yayun Ren, Elaine Chng, and Stephen A. Harrison

Differential anti-fibrotic effects of semaglutide and lanifranor demonstrated by AI DP in the biopsy-confirmed GAN BIO-MASH mouse model with advanced fibrosis and HCC

Xiao Teng, Desiree Abdurrachim, Ashmita Saigal, Qiang Yang, Gideon Ho, Malte Hasle Nielsen, Susanne E. Pors, Chih-Liang Chin, Saswata Talukdar, Asad Abu Bakar Ali, and Michael Feigh

Use of multi-parametric measures to differentiate and better assess fibrosis patterns between baselie and EOT patients in NASH clinical trials – Results from the FALCON-1 and 2 clinical trials

Kutbuddin Akbary, Dean Tai, Yayun Ren, Anne Minnich, and Edgar D. Charles

FibroSIGHT™ is Here: A New Standard in Clinical Care of MASH Patients

Categories: AASLD 2023

Impact of sampling size on variability of fibrosis assessment in liver biopsies using SHG TPE and AI analysis based fibrosis staging

NITs as continuous measure of hepatic fibrosis in NAFLD

Validation of the HI AI DP platform as an aiding tool to increase pathologist concordance on fibrosis staging in NASH

Reducing screen failure rates for NASH clinical trials using ballooning and fibrosis assessment with SHG TPE microscopy and AI analysis – results from the TANDEM trial

Spatial distribution of collagen in MASLD affects levels of N terminal pro-peptide of type III collagen (PRO-C3)

The concomitant zonal quantification of qSteatosis and qFibrosis using HI AI DP improved detection of liver injury regression post-bariatric surgery

Assessment of resmetiron-mediated reductions of steatosis and concomitant ballooning utilizing quantitative SHG imaging

Differential anti-fibrotic effects of semaglutide and lanifranor demonstrated by AI DP in the biopsy-confirmed GAN BIO-MASH mouse model with advanced fibrosis and HCC

Use of multi-parametric measures to differentiate and better assess fibrosis patterns between baselie and EOT patients in NASH clinical trials – Results from the FALCON-1 and 2 clinical trials

Connect with us

Privacy Policy